RNF43 and endometrial cancer: Yet, Roudko et al. just reported that RNF43-G659Vfs*41 was detected as a neopolypeptide that was predicted to be a highly immunogenic tumor antigen in the MSI-H subtypes of the three tumor types (colon, stomach, and endometrial cancers)35.